AbCellera Biologics Inc. Stock Performance

Open $12.75	Prev. Close $12.75	Circuit Range N/A
Day Range $12.37 - $12.89	Year Range $2.75 - $13.18	Volume 2,68,888
Average Traded $12.56

AbCellera Biologics Inc. Share Price Today

As of 19 September 2026, AbCellera Biologics Inc.'s share price is $12.64. The stock opened at $12.75, compared to its previous close of $12.75. During today's trading session, AbCellera Biologics Inc.'s share price traded between $12.37 and $12.89, with an average price of $12.63. Over the past 52 weeks, the stock has recorded a high of $13.18 and a low of $2.75. In terms of performance, AbCellera Biologics Inc.'s share price has risen by 261.66% over the last six months and is up 151.54% on a year-on-year basis.

AbCellera Biologics Inc. Share Price Chart

$12.37$12.89

AbCellera Biologics Inc. Stock Fundamentals & Key Indicators

Market Cap $3.78B	PE Ratio (TTM) -25.80	Dividend Yield N/A
EPS (TTM) $-0.49	Revenue (TTM) $75.13M	Return On Equity (TTM) -15.14%
Profit Margin -194.88%	Debt to Equity 0.07	Quarterly Earnings Growth YoY -11.76%

AbCellera Biologics Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025
Revenue	N/A	$7.32M	$6.51M	$4.24M	$17.08M	$8.96M
Net Profit	-$40.61M	-$36.93M	-$51.11M	-$45.62M	-$34.73M	-$57.12M
Net Profit Margin	N/A	-504.30%	-785.42%	-1077.24%	-203.27%	-637.84%
Income Change	N/A	9.06%	-38.39%	10.73%	23.88%	-64.48%

AbCellera Biologics Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$485.42M	$38.02M	$28.83M	$75.13M
Net Profit	$158.52M	-$146.40M	-$162.86M	-$146.41M
Net Profit Margin	32.66%	-385.00%	-564.83%	-194.88%
Income Change	N/A	-192.35%	-11.24%	10.10%

About AbCellera Biologics Inc.

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc. Historical Returns

Month	Open	Close	Change %
Sep 2026	$11.28	$12.65	+2.18%
Aug 2026	$5.68	$12.38	+116.90%
Jul 2026	$7.78	$5.71	-27.17%
Jun 2026	$6.13	$7.84	+26.86%
May 2026	$4.13	$6.18	+48.74%
Apr 2026	$3.53	$4.16	+18.88%
Mar 2026	$3.48	$3.50	-2.92%
Feb 2026	$3.56	$3.60	-0.55%
Jan 2026	$3.46	$3.62	+6.16%
Dec 2025	$3.58	$3.41	-8.82%
Nov 2025	$5.54	$3.74	-32.49%
Oct 2025	$5.08	$5.54	+10.25%

ABCL Share Price FAQs

What is AbCellera Biologics Inc. share price today?

AbCellera Biologics Inc. share price today is $12.64 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of AbCellera Biologics Inc. stock?

The 52 week high of AbCellera Biologics Inc. stock is $13.18, while the 52 week low is $2.75 as of 19 Sep '26.

What is ABCL's market capitalisation today?

ABCL market capitalisation is $3.78B as of September 19, 2026, at 4:44 am IST.

What is ABCL's net income for the last quarter?

ABCL's net income for the last quarter is -0.06B USD.

What is the 5 year returns of ABCL?

The 5 year returns of ABCL is -36.86% as on 19 Sep '26.

What is the high & low stock price of ABCL today?

ABCL stock price hit a high of $12.89 and low of $12.37 as of 19 Sep '26.

Can I buy ABCL shares in India?

Yes. You can buy ABCL in India by opening an international trading account.